The first public molecular recognition database, BindingDB supports research, education and practice in drug discovery, pharmacology and related fields.

BindingDB contains 2.8M data for 1.2M Compounds and 9.2K Targets. Of those, 1,346K data for 622K Compounds and 4.5K Targets were curated by BindingDB curators. BindingDB is a FAIRsharing resource.

If BindingDB was of value to your research, please take a moment to donate to this nonprofit project. Your donation will let us provide you with more data and improved service.

Advanced Search

16 articles for thisTarget


The following articles (labelled with PubMed ID or TBD) are for your review

PMID
Data
Article Title
Organization
Discovery of Benzothiazole Scaffold-Based DNA Gyrase B Inhibitors.EBI
University Of Ljubljana
Discovery of Pyrazolopyridones as a Novel Class of Gyrase B Inhibitors Using Structure Guided Design.EBI
Cubist Pharmaceuticals
Fragment-based discovery of DNA gyrase inhibitors targeting the ATPase subunit of GyrB.EBI
Cubist Pharmaceuticals
Discovery of Indazole Derivatives as a Novel Class of Bacterial Gyrase B Inhibitors.EBI
Cubist Pharmaceuticals
Pyridine-3-carboxamide-6-yl-ureas as novel inhibitors of bacterial DNA gyrase: structure based design, synthesis, SAR and antimicrobial activity.EBI
University Of Leeds
Optimization of pyrrolamide topoisomerase II inhibitors toward identification of an antibacterial clinical candidate (AZD5099).EBI
Astrazeneca
Computer-aided identification of novel 3,5-substituted rhodanine derivatives with activity against Staphylococcus aureus DNA gyrase.EBI
University Of The Sciences
Fragment-to-hit-to-lead discovery of a novel pyridylurea scaffold of ATP competitive dual targeting type II topoisomerase inhibiting antibacterial agents.EBI
Astrazeneca R&D Boston
Combatting Drug-Resistant Bacteria with Gyrase and Topoisomerase IV Inhibitors: Patent Highlight.EBI
TBA
Discovery of a novel azaindole class of antibacterial agents targeting the ATPase domains of DNA gyrase and Topoisomerase IV.EBI
Astrazeneca
Pyrrolamide DNA gyrase inhibitors: optimization of antibacterial activity and efficacy.EBI
Astrazeneca R&D Boston
Discovery of Azaindole Ureas as a Novel Class of Bacterial Gyrase B Inhibitors.EBI
Cubist Pharmaceuticals
Structure-guided design and development of novel benzimidazole class of compounds targeting DNA gyraseB enzyme of Staphylococcus aureus.EBI
Birla Institute Of Technology & Science-Pilani
New N-phenylpyrrolamide DNA gyrase B inhibitors: Optimization of efficacy and antibacterial activity.EBI
University Of Ljubljana
New developments in non-quinolone-based antibiotics for the inhibiton of bacterial gyrase and topoisomerase IV.EBI
Islamia College University
Linker-switch approach towards new ATP binding site inhibitors of DNA gyrase B.EBI
University Of Ljubljana